SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-12-23 16:58
Tx date 2022-12-23 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$130.00
+1,000 vol
$0.13 each 		1,360,000
Filed 2022-12-23 16:57
Tx date 2022-12-22 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,700
+20,000 vol
$0.085 each 		1,359,000
Filed 2022-12-13 20:12
Tx date 2022-12-12 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,680
+32,000 vol
$0.115 each 		1,339,000
Filed 2022-12-13 20:09
Tx date 2022-12-09 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$250.00
+5,000 vol
$0.05 each 		1,307,000
Filed 2022-10-15 02:41
Tx date 2022-10-13 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,125
+15,000 vol
$0.075 each 		1,302,000
Filed 2022-09-26 16:41
Tx date 2022-09-26 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$900.00
+9,000 vol
$0.10 each 		1,287,000
Filed 2022-09-26 16:40
Tx date 2022-09-22 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,100
+11,000 vol
$0.10 each 		1,278,000
Filed 2022-09-21 21:15
Tx date 2022-09-16 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,400
+30,000 vol
$0.08 each 		1,267,000
Filed 2022-06-22 18:59
Tx date 2022-06-22 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$420.00
+7,000 vol
$0.06 each 		1,237,000
Filed 2022-06-20 04:04
Tx date 2022-06-13 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,650
+30,000 vol
$0.055 each 		1,230,000
Filed 2022-06-07 11:16
Tx date 2022-05-16 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$950.00
+10,000 vol
$0.095 each 		1,200,000
Filed 2022-06-07 11:15
Tx date 2022-05-13 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,900
+20,000 vol
$0.095 each 		1,190,000
Filed 2021-10-25 20:35
Tx date 2021-10-21 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+5,000 vol 		1,170,000
Filed 2021-10-12 20:34
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$14,900
+149,000 vol
$0.10 each 		149,000
Filed 2021-10-12 20:33
Tx date 2021-10-04 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-12 20:33
Tx date 2021-10-04 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Holder: Gordana Vicentijevic (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2021-10-12 20:32
Tx date 2021-10-04 		$BCC
Benz Capital Corp. 		Vicentijevic, Miloje
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,165,000
Filed 2021-10-12 20:14
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$5,000
+50,000 vol
$0.10 each 		50,000
Filed 2021-10-12 14:59
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		TINTOR, NICHOLAS
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$10,000
+100,000 vol
$0.10 each 		100,000
Filed 2021-10-12 14:57
Tx date 2021-07-05 		$BCC
Benz Capital Corp. 		TINTOR, NICHOLAS
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-08 20:02
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,500
+25,000 vol
$0.10 each
Filed 2021-10-08 20:46
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		Pankiw, Christine
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$5,000
+50,000 vol
$0.10 each 		50,000
Filed 2021-10-08 20:45
Tx date 2021-07-05 		$BCC
Benz Capital Corp. 		Pankiw, Christine
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-08 20:44
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		Birmingham, Jason
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,500
+75,000 vol
$0.10 each 		75,000
Filed 2021-10-08 20:43
Tx date 2021-07-05 		$BCC
Benz Capital Corp. 		Birmingham, Jason
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-08 20:02
Tx date 2021-10-06 		$BCC
Benz Capital Corp. 		Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,500
+25,000 vol
$0.10 each 		25,000
Filed 2021-10-08 20:00
Tx date 2021-07-05 		$BCC
Benz Capital Corp. 		Bub, Gordon
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-07 13:51
Tx date 2021-10-04 		$BCC
Benz Capital Corp. 		Escribano, Carlos
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		500,000
Filed 2017-10-30
Tx date 2017-08-24 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-20,343,750 vol 		0
Filed 2017-10-30
Tx date 2017-01-19 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		20,343,750
Filed 2017-10-30
Tx date 2017-08-22 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Shamsa Alotaiba (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
-14,437,500 vol 		0
Filed 2017-10-30
Tx date 2017-01-19 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Shamsa Alotaiba (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		14,437,500
Filed 2017-10-30
Tx date 2017-08-25 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Samih Abdulrahman Basaddiq (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
-17,718,750 vol 		0
Filed 2017-10-30
Tx date 2017-01-19 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Samih Abdulrahman Basaddiq (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		17,718,750
Filed 2017-10-30
Tx date 2017-08-25 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
+17,718,750 vol 		52,500,000
Filed 2017-10-30
Tx date 2017-01-19 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		14,437,500
Filed 2017-10-30
Tx date 2017-08-24 		$BCC
The Canadian Bioceutical Corporation 		Almheiri, Naser Bin Butti
3 - 10% Security Holder of Issuer
Holder: Al Sidra Commercial Investments LLC (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
+20,343,750 vol 		34,781,250
Filed 2017-10-18
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-5,000
-100,000 vol
$0.05 each 		150,000
Filed 2017-10-18
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$30,000
+150,000 vol
$0.20 each 		400,000
Filed 2017-10-18
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$5,000
+100,000 vol
$0.05 each 		250,000
Filed 2017-10-18
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-30,000
-150,000 vol
$0.20 each 		0
Filed 2017-10-17
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$50,000
+250,000 vol
$0.20 each
Filed 2017-10-17
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-250,000 vol 		0
Filed 2017-10-17
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-150,000 vol 		250,000
Filed 2017-10-17
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-150,000 vol
Filed 2017-10-17
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$12,500
+250,000 vol
$0.05 each 		2,611,559
Filed 2017-10-17
Tx date 2017-10-17 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$30,000
+150,000 vol
$0.20 each 		2,361,559
Filed 2017-10-14
Tx date 2017-10-12 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options 		$30,000
+150,000 vol
$0.20 each 		396,000
Filed 2017-10-13
Tx date 2017-10-10 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-30,000
-150,000 vol
$0.20 each 		0
Filed 2017-07-04
Tx date 2017-06-29 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options 		$5,250
+105,000 vol
$0.05 each 		246,000
Filed 2017-05-06
Tx date 2017-05-05 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-5,250
-105,000 vol
$0.05 each 		150,000
Filed 2017-04-21
Tx date 2016-10-01 		$BCC
The Canadian Bioceutical Corporation 		Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-21
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Chu, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$100,000
+500,000 vol
$0.20 each 		500,000
Filed 2017-03-29
Tx date 2017-03-28 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,600
+20,000 vol
$0.53 each 		207,500
Filed 2017-03-20
Tx date 2017-03-17 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-7,500
-150,000 vol
$0.05 each 		250,000
Filed 2017-03-20
Tx date 2017-03-17 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$7,500
+150,000 vol
$0.05 each 		150,000
Filed 2017-02-24
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$700,000
+3,500,000 vol
$0.20 each
Filed 2017-02-24
Tx date 2017-01-23 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-24
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$700,000
+3,500,000 vol
$0.20 each
Filed 2017-02-24
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$700,000
+3,500,000 vol
$0.20 each 		3,500,000
Filed 2017-02-24
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,100,000
+3,500,000 vol
$0.60 each 		7,000,000
Filed 2017-02-24
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$3,500,000
+3,500,000 vol
$1.00 each
Filed 2017-02-24
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$3,500,000
+3,500,000 vol
$1.00 each 		10,500,000
Filed 2017-02-24
Tx date 2017-01-23 		$BCC
The Canadian Bioceutical Corporation 		Stavola, Elizabeth M.
5 - Senior Officer of Issuer
Direct Ownership
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-23
Tx date 2017-02-16 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-62,500 vol 		187,500
Filed 2017-02-23
Tx date 2017-02-16 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-62,500 vol
Filed 2017-02-23
Tx date 2017-02-16 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Eikens-Stafford (Control or Direction)
Common Shares
90 - Change in the nature of ownership
+62,500 vol 		62,500
Filed 2017-02-23
Tx date 2014-11-18 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Eikens-Stafford (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-01
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$700,000
+3,500,000 vol
$0.20 each 		3,650,000
Filed 2017-01-31
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,500
+170,000 vol
$0.05 each 		250,000
Filed 2017-01-31
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+150,000 vol
$0.20 each 		300,000
Filed 2017-01-31
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+150,000 vol
$0.20 each 		150,000
Filed 2017-01-31
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-8,500
-170,000 vol
$0.05 each 		0
Filed 2017-01-27
Tx date 2017-01-26 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options 		$1,500
+30,000 vol
$0.05 each 		141,000
Filed 2017-01-26
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+150,000 vol
$0.20 each 		400,000
Filed 2017-01-26
Tx date 2016-09-24 		$BCC
The Canadian Bioceutical Corporation 		Stott, Donald
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-386,265 vol 		250,000
Filed 2017-01-25
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+150,000 vol
$0.20 each 		255,000
Filed 2017-01-25
Tx date 2017-01-25 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$30,000
+150,000 vol
$0.20 each 		400,000
Filed 2017-01-06
Tx date 2017-01-03 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
-180,000 vol 		2,031,559
Filed 2017-01-06
Tx date 2017-01-03 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
+180,000 vol 		2,211,559
Filed 2017-01-02
Tx date 2016-12-29 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-1,500
-30,000 vol
$0.05 each 		105,000
Filed 2016-10-25
Tx date 2016-10-21 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
+2,211,559 vol 		2,211,559
Filed 2016-10-25
Tx date 2016-10-21 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-2,211,559 vol 		0
Filed 2016-10-24
Tx date 2016-09-24 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-49,800
-166,000 vol
$0.30 each 		250,000
Filed 2016-10-24
Tx date 2016-10-21 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Palm American Investments Inc. (Control or Direction)
Common Shares
97 - Other
-196,771 vol 		0
Filed 2016-09-29
Tx date 2016-09-22 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-1,750
-35,000 vol
$0.05 each 		135,000
Filed 2016-09-29
Tx date 2016-09-22 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Indirect Ownership)
Common Shares
51 - Exercise of options 		$1,750
+35,000 vol
$0.05 each 		111,000
Filed 2016-06-20
Tx date 2014-12-16 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$12,500
+250,000 vol
$0.05 each
Filed 2016-06-20
Tx date 2016-06-17 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-4,000
-80,000 vol
$0.05 each 		170,000
Filed 2016-06-20
Tx date 2016-06-17 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-40,000
-80,000 vol
$0.50 each
Filed 2016-06-20
Tx date 2014-12-16 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$12,500
+250,000 vol
$0.05 each 		250,000
Filed 2016-06-20
Tx date 2014-11-18 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-06-17 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$4,000
+80,000 vol
$0.05 each 		80,000
Filed 2016-06-17
Tx date 2016-06-17 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-40,000
-80,000 vol
$0.50 each 		170,000
Filed 2016-06-17
Tx date 2014-11-18 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-17
Tx date 2014-11-18 		$BCC
The Canadian Bioceutical Corporation 		Stafford, Randall Glenn
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-17
Tx date 2016-05-11 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-2,000
-40,000 vol
$0.05 each 		170,000
Filed 2016-05-17
Tx date 2016-05-11 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options 		$2,000
+40,000 vol
$0.05 each 		76,000
Filed 2016-01-13
Tx date 2016-01-11 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-800.00
-4,000 vol
$0.20 each 		36,000
Filed 2015-12-24
Tx date 2015-12-23 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
-19,500 vol 		2,192,059
Filed 2015-12-24
Tx date 2015-12-23 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
+19,500 vol 		2,211,559
Filed 2015-12-01
Tx date 2015-11-27 		$BCC
The Canadian Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-22,500
-125,000 vol
$0.18 each 		3,911,000
Filed 2015-11-07
Tx date 2015-11-03 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-1,250
-25,000 vol
$0.05 each 		210,000
Filed 2015-11-07
Tx date 2015-11-03 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options 		$1,250
+25,000 vol
$0.05 each 		40,000
Filed 2015-09-17
Tx date 2015-09-16 		$BCC
The Canadian Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants CSW - 2014
54 - Exercise of warrants
-615,000 vol 		50,000
Filed 2015-09-17
Tx date 2015-09-14 		$BCC
The Canadian Bioceutical Corporation 		Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$30,750
+615,000 vol
$0.05 each 		3,980,000
Filed 2015-09-17
Tx date 2015-03-20 		$BCC
The Canadian Bioceutical Corporation 		Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$30,750
+615,000 vol
$0.05 each 		3,365,000
Filed 2015-09-17
Tx date 2014-11-19 		$BCC
The Canadian Bioceutical Corporation 		Collagenna skin care products
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,750,000
Filed 2015-09-17
Tx date 2015-09-16 		$BCC
The Canadian Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$30,750
+615,000 vol
$0.05 each 		4,036,000
Filed 2015-08-14
Tx date 2015-08-12 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-800.00
-2,000 vol
$0.40 each 		2,214,559
Filed 2015-08-14
Tx date 2015-08-13 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,350
-3,000 vol
$0.45 each 		2,211,559
Filed 2015-07-31
Tx date 2015-07-29 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,850
-5,000 vol
$0.37 each 		2,216,559
Filed 2015-07-15
Tx date 2014-11-18 		$BCC
The Canadian Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-15
Tx date 2015-07-09 		$BCC
The Canadian Bioceutical Corporation 		BOYES, WILLIAM SCOTT
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$27,750
+150,000 vol
$0.185 each 		150,000
Filed 2015-07-15
Tx date 2015-07-14 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,600
-5,000 vol
$0.32 each 		2,221,559
Filed 2015-07-10
Tx date 2014-11-18 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-07-10
Tx date 2015-07-06 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-750.00
-15,000 vol
$0.05 each 		235,000
Filed 2015-07-10
Tx date 2015-07-06 		$BCC
The Canadian Bioceutical Corporation 		Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
Common Shares
51 - Exercise of options 		$750.00
+15,000 vol
$0.05 each 		15,000
Filed 2015-05-22
Tx date 2015-05-21 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,400
-5,000 vol
$0.28 each 		2,226,559
Filed 2015-05-13
Tx date 2015-05-13 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-675.00
-2,500 vol
$0.27 each 		2,231,559
Filed 2015-05-11
Tx date 2015-05-08 		$BCC
The Canadian Bioceutical Corporation 		Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-130.00
-500 vol
$0.26 each 		2,234,059